Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 4, 2013, Pages 778-785

  Jiang, Cen ^a   Dong, Danfeng ^a   Yu, Beiqin ^a   Cai, Gang ^a   Wang, Xuefeng ^a   Ji, Yuhua ^a   Peng, Yibing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Antifungals; Erg11; Ergosterol

Indexed keywords

ANTIFUNGAL AGENT; ERGOSTEROL; FLUCONAZOLE; FUNGAL PROTEIN; ITRACONAZOLE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN CDR1; PROTEIN ERG11; PYRROLE; RHODAMINE 123; RHODAMINE 6G; UNCLASSIFIED DRUG; VORICONAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BREATHING; CANDIDA TROPICALIS; CHINA; CONTROLLED STUDY; FLOW CYTOMETRY; FUNGUS ISOLATION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MITOCHONDRIAL GENE; MITOCHONDRIAL RESPIRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE;

ANTIFUNGAL AGENTS; AZOLES; CANDIDA TROPICALIS; CANDIDIASIS; CHINA; CHROMATOGRAPHY, LIQUID; ERGOSTEROL; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; REAL-TIME POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE; TANDEM MASS SPECTROMETRY;

EID: 84875276783     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks481     Document Type: Article

References (29)

1. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 21: 133-63.
2. Kontoyiannis DP, Vaziri I, Hanna HA et al. Risk factors for Candida tropicalis fungemia in patients with cancer. Clin Infect Dis 2001; 33: 1676-81.
3. Kothavade RJ, Kura MM, Valand AG et al. Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole. J Med Microbiol 2010; 59: 873-80.
4. Marr KA, Seidel K, White TC et al. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 2000; 181: 309-16.
5. Colombo AL, Guimara{ogonek}es T, Silva LR et al. Prospective observational study of candidemia in Sa{ogonek}o Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality. Infect Control Hosp Epidemiol 2007; 28: 570-6.
6. Ruan SY, Hsueh PR. Invasive candidiasis: an overview from Taiwan. J Formos Med Assoc 2009; 108: 443-51.
7. Roilides E, Farmaki E, Evdoridou J et al. Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J Clin Microbiol 2003; 41: 735-41.
8. Silva S, Negri M, Henriques M et al. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev 2012; 36: 288-305.
9. Sanguinetti M, Posteraro B, Fiori B et al. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob Agents Chemother 2005; 49: 668-79.
10. Marie C, White TC. Genetic basis of antifungal drug resistance. Curr Fungal Infect Rep 2009; 3: 163-9.
11. Morschhäuser J. Regulation of multidrug resistance in pathogenic fungi. Fungal Genet Biol 2010; 47: 94-106.
12. Brun S, Aubry C, Lima O et al. Relationships between respiration and susceptibility to azole antifungals in Candida glabrata. Antimicrob Agents Chemother 2003; 47: 847-53.
13. Helmerhorst EJ, Murphy MP, Troxler RF et al. Characterization of the mitochondrial respiratory pathways in Candida albicans. Biochim Biophys Acta 2002; 1556: 73-80.
14. Pfaller MA, Andes D, Arendrup MC et al. Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagn Microbiol Infect Dis 2011; 70: 330-43.
15. Pfaller MA, Andes D, Diekema DJ et al. Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist Update 2010; 13: 180-95.
16. Maesaki S, Marichal P, Vanden Bossche H et al. Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains. J Antimicrob Chemother 1999; 44: 27-31.
17. Peng Y, Dong D, Jiang C et al. Relationship between respiration deficiency and azole resistance in clinical Candida glabrata. FEMS Yeast Res 2012; 12: 719-27.
18. Skowronek P, Krummeck G, Haferkamp O et al. Flow cytometry as a tool to discriminate respiratory-competent and respiratory-deficient yeast cells. Curr Genet 1990; 18: 265-7.
19. Versalovic J, Koeuth T, Lupski JR. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res 1999; 19: 6823-31.
20. Vandeputte P, Larcher G, Berge's T et al. Mechanisms of azole resistance in a clinical isolate of Candida tropicalis. Antimicrob Agents Chemother 2005; 49: 4608-15.
21. Kelly SL, Arnoldi A, Kelly DE. Molecular genetic analysis of azole antifungal mode of action. Biochem Soc Trans 1993; 21: 1034-8.
22. Kalb VF, Woods CW, Turi TG et al. Primary structure of the P450 lanosterol demethylase gene from Saccharomyces cerevisiae. DNA 1987; 6: 519-37.
23. Edlind TD, Henry KW, Vermitsky JP et al. Promoter-dependent disruption of genes: simple, rapid, and specific PCR-based method with application to three different yeast. Curr Genet 2005; 48: 117-25.
24. Barchiesi F, Calabrese D, Sanglard D et al. Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Chemother 2000; 44: 1578-84.
25. Henry KW, Nickels JT, Edlind TD. Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother 2000; 44: 2693-700.
26. Dunkel N, Liu TT, Barker KS et al. A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate. Eukaryotic Cell 2008; 7: 1180-90.
27. Sanglard D, Ischer F, Koymans L et al. Amino acid substitutions in the cytochrome P-450 lanosterol 14a-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob Agents Chemother 1998; 42: 241-53.
28. Favre B, Didmon M, Ryder NS. Multiple amino acid substitutions in lanosterol 14a-demethylase contribute to azole resistance in Candida albicans. Microbiology 1999; 145: 2715-25.
29. Feng LJ, Wan Z, Wang XH et al. Relationship between antifungal resistance of fluconazole resistant Candida albicans and mutations in ERG11 gene. Chin Med J (Engl) 2010; 123: 544-8.